Selected Publications

Maxwell KN, Patel V, Nead KT, Merrill S, Clark D, Jiang Q, Wubbenhorst B, D'Andrea K, Cohen RB, Domchek SM, Morrissette JJD, Greenberg RA, Babushok DV, Nathanson KL.: Fanconi Anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood. Clin Genet. : 2022.

Sun L, Candelieri-Surette D, Anglin-Foote T, Lynch JA, Maxwell KN, D'Avella, C, Singh A, Aakhus E, Cohen RB, Brody RM.: Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer. . 2022 Sep 22. doi: 10.1001/jamaoto.2022.2791. Epub ahead of print. PMID: . JAMA Otolaryngol Head Neck Surg : 2022.

Hobday SB, Brody RM, Kriegsman B, Basu D, Newman J, Cohen RB, Lukens JN, Singh A, D'Avella CA, Sun L.: Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors JAMA Otolaryngol Head Neck Surg : 2022.

Sun L, Brody R, Candelieri D, Anglin-Foote T, Lynch JA, Maxwell KN, Damrauer S, Ojerholm E, Lukens JN, Cohen RB, Getz KD, Hubbard RA, Ky B.: Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma JAMA Otolaryngol Head Neck Surg 148 : 740-747,2022.

Bauman JE, Julian R, Saba NF, Wise-Draper TM, Adkins DR, O'Brien P, Fidler MJ, Gibson MK, Duvvuri U, Heath-Chiozzi M, Alvarado D, Gedrich R, Golden P, Cohen RB.: Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer Cancers (Basel) 14 : 2355,2022.

Thompson JC, Aggarwal C, Wong J, Nimgaonkar V, Hwang WT, Andronov M, Dibardino DM, Hutchinson CT, Ma KC, Lanfranco A, Moon E, Haas AR, Singh AP, Ciunci CA, Marmarelis M, D'Avella C, Cohen JV, Bauml JM, Cohen RB, Langer CJ, Vachani A, Carpenter EL.: Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study JTO Clin Res Rep 3 : 100301,2022.

Brody RM, Shimunov D, Cohen RB, Lin A, Lukens JN, Hartner L, Aggarwal C, Duvvuri U, Montone KT, Jalaly JB, LiVolsi VA, Carey RM, Shanti RM, Rajasekaran K, Chalian AA, Rassekh CH, Cannady SB, Newman JG, O'Malley BW, Weinstein GS, Gimotty PA, Basu D.: A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers Oral Oncol : 2022.

Ciunci CA, Reibel JB, Evans TL, Mick R, Bauml JM, Aggarwal C, Marmarelis ME, Singh AP, D'Avella C, Cohen RB, Langer CJ.: Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed Clin Lung Cancer : 2022.

Aggarwal C, Prawira A, Antonia S, Rahma O, Tolcher A, Cohen RB, Lou Y, Hauke R, Vogelzang N, P Zandberg D, Kalebasty AR, Atkinson V, Adjei AA, Seetharam M, Birnbaum A, Weickhardt A, Ganju V, Joshua AM, Cavallo R, Peng L, Zhang X, Kaul S, Baughman J, Bonvini E, Moore PA, Goldberg SM, Arnaldez FI, Ferris RL, Lakhani NJ.: Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial J Immunother Cancer : 2022.

Marmarelis ME, Yang YX, Hwang WT, Mamtani R, Singh A, Ciunci C, Aggarwal C, Cohen RB, Langer CJ.: Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of Immunotherapy Clin Lung Cancer : 2022.

Academic Contact Information

Division of Hematology-Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-139
Philadelphia, PA 19104
Phone: 215-662-4469
Patient appointments: 800-789-7366